Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of combined radiotherapy and
hormone therapy and hormone therapy alone in the treatment of clinically locally advanced
prostate cancer (T3-T4 or pT3 on biopsy, N0, M0).